Almac introduces handling and bottling capabilities in EU and US headquarters.
Almac announced that it has expanded its service offering for dispensing and bottling solid dosage products by introducing enhanced containment equipment and processes at its EU and US clinical services sites. The facilities are now in operation following successful installation and validation.
Dr Robert Dunlop, managing director of Almac clinical services said in a press release that there has been an increase in demand for facilities equipped to handle compounds of a higher potency in the drug-development industry and Almac has responded by expanding its service offering to address this need.
